Document is current
Any future updates will be listed below
-
Authors
Hajdarpašić, Aida https://orcid.org/0000-0001-8131-4084
Tukker, Martijn https://orcid.org/0000-0001-5423-4433
Rijdt, Wouter te https://orcid.org/0000-0003-4852-9379
Mohamedhoesein, Sharida https://orcid.org/0000-0002-0323-5118
Meijers, Wouter C. https://orcid.org/0000-0002-3287-6766
Caliskan, Kadir https://orcid.org/0000-0002-3293-9261
- License Information
-
More Information
Article History
Accepted: 18 October 2024
First Online: 26 November 2024
Declarations
:
: WCM received speaker/ advisory board fees from Daiichi Sankyo and Novartis.AH, MT, WtR, SM, KC had nothing to disclose and did not have any Conflict of Interest.
